Evidence map›Paper›PMID 25972479›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Thymic low affinity/avidity interaction selects natural Th1 cells.

Byung Hyun Kang, Hyo Jin Park, Hye In Yum, Seung Pyo Park, Jin Kyun Park, Eun Ha Kang, Jae-Il Lee, Eun Bong Lee, Chung-Gyu Park, Kyeong Cheon Jung and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. CD4Journal of immunology research · 2018
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Byung Hyun KangGraduate School of Immunology, Seoul National University College of Medicine, Seoul 110-799, Korea;
Hyo Jin ParkDepartment of Pathology, Seoul National University College of Medicine, Seoul 110-799, Korea; Department of Pathology, Seoul National University Bundang Hospital, SungNam 463-707, Korea;
Hye In YumGraduate School of Immunology, Seoul National University College of Medicine, Seoul 110-799, Korea;
Seung Pyo ParkTransplantation Research Institute, Medical Research Center, Seoul National University College of Medicine, Seoul 110-799, Korea;
Jin Kyun ParkDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea; Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul 110-744, Korea;
Eun Ha KangDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea; Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, SungNam 463-707, Korea;
Jae-Il LeeGraduate School of Immunology, Seoul National University College of Medicine, Seoul 110-799, Korea; Transplantation Research Institute, Medical Research Center, Seoul National University College of Medicine, Seoul 110-799, Korea;
Eun Bong LeeDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea; Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul 110-744, Korea;
Chung-Gyu ParkTransplantation Research Institute, Medical Research Center, Seoul National University College of Medicine, Seoul 110-799, Korea; Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul 110-799, Korea; Translational Xenotransplantation Research Center, Seoul National University College of Medicine, Seoul 110-799, Korea; and.
Kyeong Cheon JungGraduate School of Immunology, Seoul National University College of Medicine, Seoul 110-799, Korea; Department of Pathology, Seoul National University College of Medicine, Seoul 110-799, Korea; Transplantation Research Institute, Medical Research Center, Seoul National University College of Medicine, Seoul 110-799, Korea; Department of Pathology, Seoul National University Hospital, Seoul 110-744, Korea pshoe@snu.ac.kr jungkc66@snu.ac.kr.
Seong Hoe ParkGraduate School of Immunology, Seoul National University College of Medicine, Seoul 110-799, Korea; Transplantation Research Institute, Medical Research Center, Seoul National University College of Medicine, Seoul 110-799, Korea; pshoe@snu.ac.kr jungkc66@snu.ac.kr.
New Generation University College · ETSeoul National University Bundang Hospital · KRSeoul National University Hospital · KRNational University College · PRSeoul National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identification of intrathymic eomesodermin(+) (Eomes(+)) CD4 T cells creates a novel idea that there is more than one way for the generation of innate CD4 T cells. Promyelocytic leukemia zinc finger protein(+) T cells and natural Th17 cells are known to be generated by sensing a high and persistent TCR strength, whereas this is not the case for Eomes(+) CD4 T cells. These cells go through low-level signal during the entire maturation pathway, which subsequently leads to induction of high susceptibility to cytokine IL-4. This event seems to be a major determinant for the generation of this type of cell. These T cells are functionally equivalent to Th1 cells that are present in the periphery, and this event takes place both in transgenic and in wild-type mice. There is additional evidence that this type of Eomes(+) innate CD4 T cell is also present in human cord blood.

Indexed as

Clonal Selection, Antigen-MediatedAnimalsCD4-Positive T-LymphocytesCell DifferentiationFetal BloodGene ExpressionHistocompatibility Antigens Class IIHumansImmunity, InnateInterleukin-4Kruppel-Like Transcription FactorsMiceMice, KnockoutPhenotypePromyelocytic Leukemia Zinc Finger ProteinProtein BindingEomes protein, mouseHistocompatibility Antigens Class IIInterleukin-4Kruppel-Like Transcription FactorsPromyelocytic Leukemia Zinc Finger ProteinReceptors, Antigen, T-CellT-Box Domain ProteinsZbtb16 protein, mouse

Identifiers

PMID25972479
PMCPMC4456632
OpenAlexW1587319701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.